@yilinmdphd.bsky.social
#iwCART25 day 1 covered current state of #CellTherapy in solid tumors, CLL & ALL. Day 2 opens with activities in the next frontier: autoimmune disorders. @vjhemonc.bsky.social keynote speaker Dr. David Porter.
April 12, 2025 at 1:23 PM
#iwCART25 day 1 covered current state of #CellTherapy in solid tumors, CLL & ALL. Day 2 opens with activities in the next frontier: autoimmune disorders. @vjhemonc.bsky.social keynote speaker Dr. David Porter.
Bright sunny day in Minnesota to travel to Osaka Japan. Looking forward to international exchange in #CARTtherapy #JSTCT2025
February 24, 2025 at 4:26 PM
Bright sunny day in Minnesota to travel to Osaka Japan. Looking forward to international exchange in #CARTtherapy #JSTCT2025
Great inaugural #NashvilleHeme25: timely clinical data updates, relevant practical information, fun debates! All at the capitol of country music. Save the date for #NashvilleHeme26
February 22, 2025 at 10:04 PM
Great inaugural #NashvilleHeme25: timely clinical data updates, relevant practical information, fun debates! All at the capitol of country music. Save the date for #NashvilleHeme26
Great venue for the inaugural #nashvilleheme25 at Country Music Hall of Fame! Hematologists know how to make CME fun.
February 21, 2025 at 5:02 PM
Great venue for the inaugural #nashvilleheme25 at Country Music Hall of Fame! Hematologists know how to make CME fun.
Can we avoid the Chekov’Gun Dilemma in #CART therapy decision making? Dr. Rejeski presents prediction model at the time of eval, prior to leukapheresis #ASH24 data from >800 #mmsm pts (abstract 895) @drmiguelperales.bsky.social
December 9, 2024 at 10:56 PM
Can we avoid the Chekov’Gun Dilemma in #CART therapy decision making? Dr. Rejeski presents prediction model at the time of eval, prior to leukapheresis #ASH24 data from >800 #mmsm pts (abstract 895) @drmiguelperales.bsky.social
